1116 (1116) Fair Value & Analysis

Basic Materials · Market cap HK$421M

1 1116 1116 · HK

PriceHK$0.2000

Fair ValueHK$0.0800

Upside-60.0%

Quality44/100

Evidence: Low Range HK$0.0500 – HK$0.1200

Fair value as of: Jul 2, 2026

From 3 valuation models · updated today

Share price −18.0% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.2000 – HK$0.3750 · fair‑value band HK$0.0500 – HK$0.1200 · the HK$0.2000 price screens above the HK$0.0800 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1116 (1116) currently trades at HK$0.2000, while our model-based Fair Value estimate is HK$0.0800 — implying the stock looks roughly 60.0% overvalued today. We read business quality at 44/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 1116 generated revenue of HK$819M at a net margin of -5.8%. Revenue grew 14.9% year over year. It earns a return on equity of -26.7%. Net debt stands at HK$111M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$819M

Revenue growth (YoY) +14.9%

Net margin -5.8%

Return on equity -26.7%

Free cash flow −HK$72.1M FY2024

Operating margin 0.8%

More key figures

EPS (TTM) HK$-0.0400

EPS growth (YoY) +3,073%

Net debt HK$111M FY2024

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1116 reported revenue of HK$819M in FY2025 versus HK$692M in FY2021, a compound +4.3%/yr. Reported net income was −HK$47.7M in FY2025.

Revenue +4.3%/yr

FY21 HK$692M

FY22 HK$538M

FY23 HK$714M

FY24 HK$760M

FY25 HK$819M

Net income

FY21 −HK$6.3M

FY22 −HK$339M

FY23 −HK$14.7M

FY24 −HK$57.7M

FY25 −HK$47.7M

Is 1116 fairly valued? → Check now

Similar stocks

6 more Steel stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Tata Steel Limited TTST	$0.2110	$0.0100	-95%
Nucor Corporation NUE	$254.39	$83.10	-67%
ArcelorMittal S.A ARMT34	R$166.77	R$110.23	-34%
JSW Steel Limited JSWSTEEL	₹1,282	₹1,113	-13%
China Steel Corporation 2002A	38.45 TWD	11.94 TWD	-69%
Baoshan Iron & Steel Co 600019	¥5.74	¥7.78	+36%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1116 (1116) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.0800 versus a price of HK$0.2000 — about −60% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1116?

Our model-based fair value for 1116 is HK$0.0800 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.2000.

What is the quality score of 1116?

1116 has a Quality Score of 44/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1116 (1116)?

1116 reported trailing-twelve-month revenue of about HK$819M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1116?

The net profit margin of 1116 is about -5.8%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.